Niagen: High-Quality Growth At A Fair Price

Understand this faster with AI
Bela Lakos1.53K FollowersFollow5ShareSavePlay(6min)CommentsSummaryNiagen's fiscal 2025 revenue growth and profitability improvement can make the stock attractive for growth-focussed investors.The company's low debt levels and relatively high amount of cash on hand allow them financial flexibility, even during market distress.Macroeconomic headwinds exist, especially low consumer confidence and high energy prices, but share issuance also poses a threat to existing shareholders.I rate NAGE as a buy due to the high growth and fair valuation. Daniel Grizelj/DigitalVision via Getty Images Niagen Bioscience (NAGE) is a high-growth, high-profitability firm that may catch the eye of many growth-focussed investors. In fiscal 2025, they grew their net sales by 30%, they expanded their profitability by 2.5 percentage points, and they moreThis article was written byBela Lakos1.53K FollowersFollowPetroleum engineer with an enthusiasm for investing, accounting and personal finances.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Past performance is not an indicator of future performance. This post is illustrative and educational and is not a specific offer of products or services or financial advice. Information in this article is not an offer to buy or sell or a solicitation of any offer to buy or sell the securities mentioned herein. Information presented is believed to be factual and up-to-date, but we do not guarantee its accuracy, and it should not be regarded as a complete analysis of the subjects discussed. Expressions of opinion reflect the judgment of the authors as of the date of publication and are subject to change.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Tags
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
